Identification of Mrm2 as a Key Regulator in Mitochondrial Dysfunction During Radiation-Induced Intestinal Injury.

Area of Science:

• Mitochondrial biology
• Radiation oncology
• Gastrointestinal pathology

Background:

• Radiation-induced intestinal injury (RIII) is a severe clinical complication of radiotherapy.
• Mitochondrial dysfunction is implicated in RIII pathogenesis, but underlying mechanisms are not fully understood.

Purpose of the Study:

• To investigate the molecular mechanisms of RIII, focusing on mitochondrial dysfunction.
• To identify key genes and pathways involved in the development of RIII.

Main Methods:

• Development of a radiation-induced intestinal injury model.
• Identification of differentially expressed mitochondrial-related genes using transcriptomic analysis.
• Histopathological examination to assess RIII severity.
• Quantitative analysis of specific gene expression (Mrm2) in irradiated tissues.

Main Results:

• RIII severity demonstrated a significant dose- and time-dependent increase following irradiation.
• A set of mitochondrial-related genes were identified as differentially expressed in the RIII model.
• Core functional modules included mitochondrial-coding and apoptosis-related genes.
• The gene Mrm2 was found to be continuously upregulated in irradiated intestinal tissues *in vivo*.

Conclusions:

• Mitochondrial dysfunction plays a critical role in the development of RIII.
• Mrm2 may function as a key regulatory factor in radiation-induced mitochondrial dysfunction and intestinal injury.